Lentigo maligna: diagnosis and treatment
- PMID: 19914456
- DOI: 10.1016/j.cps.2009.08.006
Lentigo maligna: diagnosis and treatment
Abstract
Lentigo maligna is an overgrowth of atypical melanocytes at the dermal-epidermal junction also known as melanoma in situ. Left untreated, these lesions can continue to grow, resulting in dermal invasion and progression to lentigo maligna melanoma. Many operative and nonoperative treatments have been developed with the goals of preserving function and cosmesis while at the same time addressing the diffuse nature of these lesions. Previous recommendations have led plastic surgeons to commonly perform wide local excision with 5 mm margins. More recent literature has suggested that in many cases this treatment can result in high recurrence rates. This has led to margin control procedures becoming the treatment of choice for these lesions.
Similar articles
-
Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment.Dermatol Surg. 2006 Apr;32(4):493-504. doi: 10.1111/j.1524-4725.2006.32102.x. Dermatol Surg. 2006. PMID: 16681656 Review.
-
Lentigo maligna: review of salient characteristics and management.Am J Clin Dermatol. 2013 Dec;14(6):473-80. doi: 10.1007/s40257-013-0044-6. Am J Clin Dermatol. 2013. PMID: 24019181 Review.
-
Lentigo maligna and lentigo maligna melanoma.J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):913. J Am Acad Dermatol. 1997. PMID: 9204053 No abstract available.
-
Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.Arch Dermatol. 2004 Sep;140(9):1087-92. doi: 10.1001/archderm.140.9.1087. Arch Dermatol. 2004. PMID: 15381549
-
Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.Hum Pathol. 2000 Jun;31(6):705-8. doi: 10.1053/hupa.2000.7640. Hum Pathol. 2000. PMID: 10872664
Cited by
-
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.Cells. 2019 Jul 31;8(8):803. doi: 10.3390/cells8080803. Cells. 2019. PMID: 31370278 Free PMC article. Review.
-
Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream.Cancers (Basel). 2023 Feb 28;15(5):1546. doi: 10.3390/cancers15051546. Cancers (Basel). 2023. PMID: 36900337 Free PMC article.
-
Practical application of laser reflectance confocal microscopy in the follow-up of patients with lentigo maligna undergoing treatment with Imiquimod.An Bras Dermatol. 2022 Jul-Aug;97(4):520-522. doi: 10.1016/j.abd.2021.01.008. Epub 2022 Jun 9. An Bras Dermatol. 2022. PMID: 35691735 Free PMC article. No abstract available.
-
Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study.Acta Derm Venereol. 2021 Feb 19;101(2):adv00405. doi: 10.2340/00015555-3755. Acta Derm Venereol. 2021. PMID: 33521835 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical